pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
the cabinet

Drugs

8,127 products tracked

★ save view↓export CSV
phase
allMarketedPhase 3Phase 2Phase 1Preclinical
sort
catalystsrecentname
therapeutic area
allOncology1831Infectious Disease718Cardiology425Pulmonology396Immunology371Ophthalmology368Dermatology300Women's Health
viewlistcards
Phase 1
RLA-23174
Kidney Fibrosis
Rila Therapeutics Inc
0 catalysts
Phase 2
RLF-TD011
Dystrophic Epidermolysis Bullosa
$RLFTYMindMaze Therapeutics Holding SA
0 catalysts
Phase 2
RLS-1496
Actinic (Solar) Keratosis
Rubedo Life Sciences Inc
0 catalysts
Phase 2
RM-718
Obesity
← prev
page 149 of 271
next →
131
Pain89
Neurology1
$RYTMRHYTHM PHARMACEUTICALS, INC.
0 catalysts
Phase 2
RN-0361
Familial Chylomicronemia (Type I Hyperlipoproteinemia)
Rona Therapeutics Inc
0 catalysts
Preclinical
RNA Nanoparticle Gene Therapy
Craniofacial Bone Defects
University of Iowa
0 catalysts
Preclinical
RNAT-89
Anemia in Chronic Kidney Disease (Renal Anemia)
RNA Therapeutics Inc
0 catalysts
Phase 2
RNDP-001
Parkinson's Disease
Kenai Therapeutics Inc
0 catalysts
Phase 2
RNK-05047
Diffuse Large B-Cell Lymphoma
Ranok Therapeutics Co Ltd
0 catalysts
Phase 2
RNS-60
Acute Ischemic Stroke
Revalesio Corp
0 catalysts
Preclinical
RO-104
Wet (Neovascular / Exudative) Macular Degeneration
RevOpsis Therapeutics Inc
0 catalysts
ROBINUL
ROBINUL (GLYCOPYRROLATE)
Hikma Pharmaceuticals Plc
0 catalysts
Marketed
ROPINIROLE HYDROCHLORIDE
ROPINIROLE HYDROCHLORIDE (ROPINIROLE HYDROCHLORIDE)
Parkinson's Disease
Orchid Pharma Inc
0 catalysts
Phase 1
ROSE-12
Solid Tumor
Chugai Pharmaceutical Co Ltd
0 catalysts
ROSYRAH
ROSYRAH (LEVONORGESTREL AND ETHINYL ESTRADIOL AND ETHINYL ESTRADIOL)
XIROMED
0 catalysts
ROXICET
ROXICET (ACETAMINOPHEN)
Hikma Pharmaceuticals Plc
0 catalysts
Marketed
ROXICODONE
ROXICODONE (OXYCODONE HYDROCHLORIDE)
Pain
SpecGx LLC
0 catalysts
Preclinical
RP-001
Breast Cancer
Recurv Pharma Inc
0 catalysts
Phase 2
RP-323
Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia)
PhorMed Inc
0 catalysts
Phase 3
RP-901
Osteoarthritis
Risen(Shanghai) Pharma Tech Co Ltd
0 catalysts
Phase 2
RPA-501
Glycogen Storage Disease (GSD)
$RCKTROCKET PHARMACEUTICALS, INC.
0 catalysts
Phase 1
RPA-601
Cardiomyopathy
$RCKTROCKET PHARMACEUTICALS, INC.
0 catalysts
Phase 1
RPA-701
Dilated Cardiomyopathy
$RCKTROCKET PHARMACEUTICALS, INC.
0 catalysts
Phase 2
RPESCRPE-4W
Dry (Atrophic) Macular Degeneration
Luxa Biotechnology LLC
0 catalysts
Phase 1
RQ-01
Coronavirus Disease 2019 (COVID-19)
Red Queen Therapeutics Inc
0 catalysts
Preclinical
RS-5
Soft Tissue Sarcoma
Resolute Science Inc
0 catalysts
Preclinical
RSBT-001
Coronavirus Disease 2019 (COVID-19)
RS BioTherapeutics Inc
0 catalysts
Phase 2
RSLV-132
Post-Acute Sequelae of COVID 2019 (PASC or Long COVID)
Resolve Therapeutics LLC
0 catalysts
Preclinical
RSV DT-preF
Respiratory Syncytial Virus (RSV) Infections
Calder Biosciences Inc
0 catalysts
Phase 1
RSY-248
Enteritis
Rasayana Therapeutics Inc
0 catalysts